Pramipexole-treated Parkinson's disease during pregnancy
β Scribed by Marco Mucchiut; Enrico Belgrado; Daniela Cutuli; Angelo Antonini; Paolo Bergonzi
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 41 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
There are few reports about drugβrelated effects on PD pregnancy. We describe the case of a woman affected by PD treated with pramipexole monotherapy during pregnancy. The child, born by caesarean delivery, is healthy, whereas motor disability of the mother progressively increased to the point that levodopa therapy was necessary. Β© 2004 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Body weight changes occur during the clinical course of Parkinson's disease (PD) and with surgical treatment, but the effect of dopaminergic treatment on weight is unknown. Body mass index (BMI), Hamilton depression scale score (HDS), and Unified Parkinson's Disease Rating Scale III (UP
Pregnancy in patients with Parkinson's disease (PD) is a rare occurrence. Previous reports based on retrospective analysis suggest that pregnancy may have a deleterious effect on PD. We describe the effects of pregnancy on the symptomatology of a 33-year-old woman with PD using quantitative neurolog